| Q34061082 | Antidepressants: past, present and future |
| Q70516340 | Changes in rat dopamine- and serotonin function in vivo after prolonged administration of the specific 5-HT uptake inhibitor, citalopram |
| Q48497115 | Chlorimipramine, electroconvulsive shock and combination thereof: differential effects of chronic treatment on apomorphine-induced behaviours and on striatal and mesocortical dopamine turnover |
| Q40137447 | Chronic antidepressant therapy and associated changes in central monoaminergic receptor functioning |
| Q48856290 | Clinical strategies for evaluating ect mechanisms — pharmacological, biochemical and psychophysiological approaches |
| Q71479809 | D1 receptor binding in rat striatum: modification by various D1 and D2 antagonists, but not by sibutramine hydrochloride, antidepressants or treatments which enhance central dopaminergic function |
| Q40139757 | Dopamine and depression: A review of recent evidence. III. The effects of antidepressant treatments |
| Q68462590 | Effect of repetitive electroconvulsive treatment on sensitivity to pain and on [3H]nitrendipine binding sites in cortical and hippocampal membranes |
| Q41141018 | Effects of chronic electroconvulsive shock on interstitial concentrations of dopamine in the nucleus accumbens |
| Q41866927 | Electroconvulsive shock enhances striatal dopamine D1 and D3 receptor binding and improves motor performance in 6-OHDA-lesioned rats. |
| Q54049344 | Neuropeptide Y in brains of the Flinders Sensitive Line rat, a model of depression. Effects of electroconvulsive stimuli and d-amphetamine on peptide concentrations and locomotion. |
| Q28336187 | Pharmacology in vivo of the phenylindan derivative, Lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brain |
| Q67296295 | Regional GABA concentration and [3H]-diazepam binding in rat brain following repeated electroconvulsive shock |
| Q72837022 | Repeated treatment with antidepressant drugs increases the behavioural response to apomorphine |